crossover
    2013

    Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects

    Harris CB, Chowanadisai W, Mishchuk DO, Satre MA, Slupsky CM, Rucker RB

    Published in Clinical Nutrition

    Key Findings

    PQQ 0.3 mg/kg/day reduced plasma CRP and IL-6 and shifted urinary metabolites consistent with enhanced mitochondrial-related metabolism.

    Conclusions

    Short-term PQQ altered inflammatory and mitochondrial metabolite markers in humans.

    Limitations

    Ten subjects, biomarker endpoints only, no clinical outcomes.

    Supplements Studied

    PQQ
    Compound

    PQQ 0.3 mg/kg/day reduced plasma CRP and IL-6 and shifted urinary metabolites consistent with enhanced mitochondrial-related metabolism.

    Outcomes Measured

    Antioxidant Protection

    PQQ reduced plasma CRP and IL-6 and shifted metabolites consistent with enhanced mitochondrial metabolism.

    Study Details

    Year:2013
    Sample Size:10
    Duration:1 weeks
    Quality Score:4/10

    Access Study

    View on DOIOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.